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ABSTRACT
Cardiovascular disease (CVD) is the first cause of death in the world, CVD has complex and multifactorial process 
including atherogenic lipoprotein, oxidized low density lipoprotein (LDL), endothelial dysfunction, plaque stability, 
vascular inflammation, thrombotic and fibrinolytic disorder, exercises and genetic factor. Inhibiting the platelet ag-
gregation is one of the CVD prevention. Velvet bean seed (Mucuna pruriens L.) can be found abundantly in Indonesia, 
but has not been used as herbal medicine. Ethanol extract and ethyl acetate of velvet bean seed contain high flavonoids 
and antioxidants properties which is expected could inhibit platelet aggregation. The objectives of the research were 
to determine the activity of ethanol extract and ethyl acetate fraction of velvet bean seed towards clotting and bleeding 
time in dyslipidemic rats. This research used completely randomized design in dyslipidemic rats which were given by 
ethanol extract of velvet bean seed at the concentrations of 50, 100 and 200 mg/kg BW/day and ethyl acetate fraction 
of velvet bean seed at the concentrations of 15, 30 and 60 mg/kg BW/day and 42.2 mg/kg BW/day aspirin for ten days. 
Clotting and bleeding time were measured at days 0, 10, and 20. Data were analyzed using One way analysis of vari-
ance and continued with Duncan’s post Hoc test with 95 % level of significancy. The results showed that administration 
of 60 mg/kg BW/day ethyl acetate fraction of velvet bean seed and at the concentrations of 100 and 200 mg/kg BW/
day ethanol extract of velvet bean seed, prolong the clotting time at day 10, ethyl acetate fraction at the concentration 
of 60 mg/kg BW/day, 200 mg/kg BW/day ethanol extract of velvet bean prolong bleeding time at day 10.
Keywords : antiaplatelet, flavonoid, platelet aggregation, Mucuna pruriens L., cardiovascular disease, dyslipidemic
INTRODUCTION
Cardiovascular disease (CVD) is the first cause of death 
in the world; around 19.8 % from total death in 1993 and be-
come 24.4 % in 1998. An estimated 17.1 million people died 
from CVD in 2004, representing 29% of all global deaths. Of 
these deaths, an estimated 7.2 million were due to CVD and 
5.7 million were due to stroke (AHRQ, 2003; WHO, 2009). 
Incidence of CVD is increasing in developed countries, the 
incidences are estimated to be three to four times higher in 
developing countries. Globally, CVD is estimated 31 % of 
the worldwide mortality. Each year 17.2 million people die 
of CVD, 80 % of them in the developing world and emerg-
ing economies. By 2030, almost 23.6 million people will die 
from CVD, mainly from heart disease and stroke. These are 
projected to remain the single leading causes of death. The 
largest percentage increase will occur in the Eastern Medite-
ranian Region. The highest increase in number of death will 
occur in the South-East Asia Region (WHO, 2009). Based on 
the data of Medical Department and Yayasan Penyakit Jan-
tung (Cardiac Disease Foundation) showed that CVD is the 
leading cause of death in Indonesia. Based on World Health 
Organization (WHO) data, around 12 million people died of 
heart attack in the world. According to the family health sur-
vey (survei kesehatan rumah tangga) in 1992, CVD causes 
around 16 % of death and become 26.4 % in 2001 (Irawan, 
2007).
Atherosclerosis is the main cause of CVD with complex 
and multifactorial process involving genetic and environment 
factors. The risk factors of CVD are atherogenic lipoprotein, 
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oxidized low-density lipoprotein (LDL), endothelial dysfunc-
tion, plaque instability, vascular inflammation, thrombotic and 
fibrinolytic disorder, exercises and genetic factor (Wijaya, 
1998; Halliwel and Gutteridge, 1999). Atherosclerosis is an 
inflammatory disease and high plasma cholesterol concentra-
tions, in particular those of LDL cholesterol, is one of the prin-
cipal risk factor of atherosclerosis. If LDL particles become 
trapped in an artery, they can undergo progressive oxidation 
and be internalized by macrophages by means of the scaven-
ger receptors on the surfaces of these cells (Ross, 1999). The 
internalization leads to the formation of lipid peroxides and fa-
cilitates the accumulation of cholesterol esters. Oxidized LDL 
may also be involved in atherogenesis by inducing smooth 
muscle cell proliferation and smooth muscle foam cell gen-
eration (Holvoet et al., 1998). Subendothelial accumulation of 
foam cells plays a key role in the initiation of atherosclerosis. 
These foam cells may be generated by the uptake of oxidized 
LDL and/or malondialdehyde (MDA)-modified LDL (Holvo-
et et al., 1998; Ross, 1999). Numerous in vitro studies using a 
variety of oxidation methods and measurements have shown 
that polyphenolics from red wine, green tea and chocolate can 
inhibit LDL oxidation (Anderson et al., 2001).
Platelet aggregation is an important factor in thrombosis 
with uncontrolable clotting blood (Wu et al., 2007). Formation 
of platelet aggregates in an atherosclerotic vessel can cause 
total blockage of blood flow, leading to myocardial infarc-
tion and thromboembolic diseases. Atherosclerosis promotes 
increased adhesiveness in the endothelial wall for platelets, 
and a lost of anticoagulant properties, which contribute to 
atherosclerotic plaque formation. Platelets adhesion is initi-
ated when platelets contact with exposed connective tissue of 
injured tissues. Adhesion stimulates platelets to secrete a vari-
ety of factors, including fibrinogen and von Willebrand factor, 
which facilitates aggregation and platelet plaque on the ves-
sel wall. Activated platelets also secrete thromboxane A2 that 
further stimulates platelet aggregation, and the activated im-
mune cells also secrete platelet activating factor (PAF) which 
stimulate platelet aggregation (Boik, 1996; Geraldo, 2010). 
The activated platelets change shape, put out pseudopodia, 
discharge their granules, and stick to other platelets thus ini-
tiating the process of platelets aggregation (Resh and Ernst, 
1995; Klepser and Klepser, 1999; El-Sabban, 2009). The 
rupture of plaques is the most important mechanism for the 
progression of vascular disease because this rupture exposes 
thrombogenic subendothelial matrix of protein and collagen, 
triggering a cascade of platelet activity (Geraldo, 2010).
Flavonoids are component of a wide variety of ed-
ible plants, fruits, and vegetables and of beverage appears 
to have antioxidative properties toward LDL, lipid peroxi-
dation (Fuhrman et al, 1995; Sesso et al., 2003). Flavonoid 
from Garcinia cambogia inhibit atherosclerosis, endothelial 
damaged, leucocyte activation, platelet adhesion and platelet 
aggregation (Koshy et al., 2001). According to the previous 
research by Widowati and Retnaningsih (2007) antioxidant 
activity in ethanol extract and ethyl acetate fraction of velvet 
bean seed (Mucuna pruriens L.) compared with α-tocopherol, 
ascorbic acid and butylated hydroxytoluen (BHT), ethanol 
extract and ethyl acetate fraction of velvet bean seed contain 
higher flavonoid compared to the others fraction (hexane 
fraction, butanol and water fraction) (Widowati et al., 2007; 
Widowati et al., 2010), thus this compound can be possibly 
used as antiaggregation platelet agent.
Many drugs as antiplatelet agents for treating CVD, 
however some have several collateral effects and resistance in 
long term therapy, such as the known clinical aspirin resistance 
(Geraldo, 2010). Thus, the purpose of this research is to de-
velop new antiplatelets agents with low collateral effects, from 
ethanol extract and ethyl acetate fraction of velvet bean seed.
MATERIALS AND METHODS
Extraction and Fractionation
The velvet bean seed (Mucuna pruriens L.) was collect-
ed from Sukoharjo Dstrict, Central Java, Indonesia, during 
April, 2007. Five kilograms of velvet bean seeds were milled 
and soaked in distilled ethanol (EtOH) and extracted by mac-
eration technique; evaporated filtrate and yielded 516.845 g 
(10.335 %) ethanol extract of velvet been seed. The ethanol 
extract (133.889 g) was partitioned with solvent mixture of 
75% n-hexane and 25 % water, produced 30.466 g (22.71 %) 
hexane fraction and the water filtrate residue was partitioned 
with solvent mixture of 95 % ethyl acetate and 5 % water, 
produced 0.498 g (0.37 %) ethyl acetate fraction and the wa-
ter filtrate residue was partitioned with solvent mixture of 90 
% n-buthanol and 10 % water, produced 3.578 g (2.67 %) 
ethyl acetate fraction. Finally, the water filtrate residue was 
evaporated and produced 4.358 g (3.26 %) water fraction. In 
this study, we used ethanol extract and ethyl acetate fraction 
of velvet bean seed, since the previous in vitro study showed 
that ethanol extract and ethyl acetate fraction of velvet bean 
seed had the highest antioxidant activity.
Animals and Diets
Thirty adult male Wistar rats obtained from School of 
Life Science, Bandung Institute of Technology, were housed 
in standard cages provided with food and water ad libitum. 
Rats were adapted for 7 days until the body weight were 
175-200 g. The rats were feed by high fat diet (3000 g stan-
dard diet mixed with 250 g duck egg yolk, 500 g palm oil, 
1250 g wheat flour, 500 g lamb fat and hot water). The rats 
which feed with high fat diet showed the average percentage 
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of crude fat was 20.78 % compared to the standard diet rats 
which was only 7.37 % .
In spite of high fat diet, each rat was also given with 1 
mL/day fructose liquid 60 % (120 g/200 mL aquadest). The 
high fat diet and fructose liquid were given for 2 weeks until 
the body weight achieved 200 – 250 g, but the high fat diet 
was still given continually for 20 days. The ethanol extract 
and ethyl acetate fraction of velvet bean seed were given only 
for 10 days.
Rats were devided into 9 groups (3 rats) with differ-
ent treatments. The first group, as negative control, was given 
standard diet. The second group, as positive control, was 
given high fat diet. The third, fourth, and fifth groups were 
treated with high fat diet plus ethyl acetate fraction 15 mg/
kg BW, 30 mg/kg BW and 60 mg/kg BW daily. The sixth, 
seventh and eighth groups were treated with high fat diet plus 
ethanol extract 50 mg/kg BW, 100 mg/kg BW and 200 mg/
kg BW daily. Group ninth was treated with high fat diet and 
aspirin 42,2 mg/kg BW daily. 
Sample Preparation for The Lipid Test and MDA
After the treatments, 1.5 mL blood from orbital vein was 
collected in the tube contained heparin. It was centrifuged at 
3,000 rpm for 10 minutes and the plasma was used for mea-
suring the total cholesterol, LDL-cholesterol, high-density li-
poprotein (HDL-cholesterol), triglyceride, and MDA level.
Total plasma cholesterol and triglyceride were measured 
according to the instruction manuals by the diagnostic kits from 
Abbott Clinical Chemistry (Abbott Clinical Chemistry, 2006), 
HDL-cholesterol, LDL-cholesterol were measured according 
to the instruction manuals of the diagnostic kits from Daiichi 
Pure Chemicals Co., Ltd (Daiichi Pure Chemical, 2008).
After feeding high fat diet and fructose for 2 weeks, 
the lipid profile of negative control group (standard diet) was 
as follow : total cholesterol 58.33 mg/dL, LDL 8.00 mg/dL, 
HDL 33.00 mg/dL, triglyceride 63.67 mg/dL and the dyslipi-
demic rats had total cholesterol 70.67 mg/dL, LDL 14.33 mg/
dL, HDL 24.33 mg/dL, and triglyceride 112.33 mg/dL. Thus, 
feeding with high fat nutrient induced dylipidemic rats.
Clotting Time Assay
The rat’s tail was injured, blood collected with capillary 
tube for 30 seconds. Capillary tube was broken every 15 sec-
onds until the fibrin filament appeared at the broken capillary 
tube as clotting time. Clotting time was measured at days 0, 
10 and 20.
Bleeding Time Assay
The rat’s tail was injured, blood absorbed with filter pa-
per for 15 seconds. The interval time between the first dropping 
blood until the flowing blood stopped was calculated as bleed-
ing time. Bleeding time was measured at days 0, 10 and 20.
Statistical Analysis
To verify the statistical significance of all parameters, 
the data were calculated the values of means and standard 
deviation (M ± SD) and 95 % confidence interval (CI) of 
means. This research used completely randomized design. 
To compare several groups, analysis of variance (ANOVA) 
was used. P-values of less than 0.05 were considered as sta-
tistically significant. Furthermore to know the best treatmet, 
Duncan’s post-Hoc test at 95 % confidence interval was used. 
Statistical analysis was done using SPSS 16.0 version.
RESULTS AND DISCCUSSION 
Based on the statistical analysis, at day 10 showed that 
HDL, LDL and MDA significantly different among treatmet, 
high fat diet significantly increased the LDL-cholesterol, de-
creased the HDL-cholesterol and decreased MDA compared 
to standard diet (Table 1). Extract and ethyl acetate fraction of 
Table 1.  HDL, LDL and MDA level in dyslipidemic rats treated with ethanol extract and ethyl acetate fraction of velvet bean seed 
for 10 days
Treatment  LDL level(mg/dL)
HDL level
(mg/dL)
MDA level
(mmol/L)
Negative control 8.00±1.00  ab 33.00±2.67 c 5.52±0.67 ab
Positive control 14.33±1.53 cd 24.33±1.53 a 11.77±1.13 c
Ethyl acetate fraction 15 mg/kg BW/day 10.00±2.00 ab 25.33±3.22 ab 5.62±0.18 ab
Ethyl acetate fraction 30 mg/kg BW/day 8.33±2.52 ab 26.67±2.3 abc 4.06±0.55 ab
Ethyl acetate fraction 60 mg/kg BW/day 7.33±1.53 a 29.67±1.15 abc 3.39±0.22 a
Ethanol extract 50 mg/kg BW/day 11.33±2.52 bc 26.33±3.51 abc 6.03±2.35 b
Ethanol extract 100 mg/kg BW/day 10.33±1.53 ab 28.67±5.51 abc 5.54±1.35 ab
Ethanol extract 200 mg/kg BW/day 11.67±3.22 bc 31.67±3.51 bc 5.14±1.86 ab
Aspirin 42,2 mg/kg BW/day 15.33±1.53 d 26.33±3.51 abc 9.60±1.61 c
Results are expressed means ± SD, Duncan post Hoc test are shown by little letter, different letter at the same coloumn are significantly different among treatment 
groups at confidence interval 95 %
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velvet bean seed decreased the LDL level and ethanol extract 
of velvet bean seed 200 mg/kg BW/day increased HDL level 
in dyslipidemic rats. Extract and ethyl acetate fraction of vel-
vet bean decreased the MDA level in dyslipidemic rats.
After treatment with various doses of ethanol extract, 
ethyl acetate fraction of velvet bean seed, and aspirin 42.2 mg/
kg BW/day for 10 days, the effect on clotting time was shown 
in Table 2. Based on the statistical analysis, at day 0, clotting 
time showed no significant difference among groups because 
at day 0 rats had not been given with ethanol extract, ethyl 
acetate and aspirin yet. At day 10, clotting time showed sig-
nificant difference among groups because rats had been given 
ethanol extract and etyhl acetate fraction. At day 20, clotting 
time showed no significant difference among groups because 
the ethanol extract, ethyl acetate and aspirin had been stopped 
at day 10, indicated that ethanol extract and ethyl acetate frac-
tion had no effect on clotting time after the treatment had been 
stopped. To determine the difference of the clotting time (days 
0, 10 and 20) among treatment groups, we analyzed using 
Duncan’s post Hoc test (Table 2), which showed the effect of 
treatments (ethanol extract and ethyl acetate fraction of velvet 
bean seed) towards clotting time. At day 10, the clotting time 
of the dyslipidemic rats treated with ethyl acetate fraction 60 
mg/kg BW/day and ethanol extract 100 and 200 mg/kg BW/
day were significant difference compared to positive control 
and had similar effect with aspirin as anticoagulant. 
Based on statistical analysis, at day 0, the bleeding time 
showed no significant difference among treatmet groups. 
While, at day 10, bleeding time showed significant difference 
among treatment groups, since rats had been given ethanol 
extract and etyhl acetate fraction. At day 20, bleeding time 
showed significant difference among treatment groups al-
though the ethanol extract, ethyl acetate and aspirin had been 
stopped at day 10, indicated that ethanol extract and ethyl 
acetate still influenced the bleeding time. To determine the 
difference of the bleeding time (0, 10 and 20 days) among 
treatment groups, we analysed using Duncan’s post Hoc test 
(Table 3), which showed that on day 0, no significant dif fe-
rence in bleeding time among treatment groups. At day 10, 
the bleeding time showed that ethyl acetate group (60 mg/
kg BW/day) was significant difference compared to positive 
control, even showed a better result compared to group treat-
 ed with aspirin as anticoagulant. At day 20, the shortest bleed -
ing time was only in positive control (dyslipidemic rats), 
negative control, rats given ethyl acetate fraction 60 mg/kg 
BW/day and rats given with aspirin were significant diffe-
rence compared to positive control. Although aspirin and 
ethyl acetate fracti on had been stopped at day 10, it means that 
aspirin and ethyl acetate fraction could prolong the bleeding 
time until day 20. 
Based on the clotting time data (Table 2) at day 10 indi-
cated that dyslipidemic rats were given with extract and ethyl 
acetate prolonged clotting time compared to positive control. 
The bleeding time (Table 3) at days 10 and 20 in dyslipidemic 
rats were shorter than negative control. At day 10 showed that 
the dyslipidemic rats which were given ethanol extract and 
ethyl acetate fraction prolonged the bleeding time. This re-
search was verified by previous study that hyperlipidemic in 
rats exhibit significant increase in ADP or collagen-induced 
platelet aggregation and cholesterol/phospholipid molar ratio 
in platelets. The increase in cholesterol/phospholipid ratio was 
responsible for hyperaggregation of platelet in animals (No-
bukata, 1999). This data was verified with previous research 
that high cholesterol consumption can induce dyslipidemic 
and endothelial damaged, also effect thrombocyte adhesion 
in collagen furthermore activate thombocyte (Aprami, 1993; 
Tabel 2. The clotting time of dyslipidemic rats treated with ethanol extract and ethyl acetate of velvet bean seed
Treatment Clotting time0 day
Clotting time
10 day
Clotting time
20 day
Negative control 105 ± 15.00 80 ± 17.32 ab 85 ± 8.66 
Positive control 90 ± 0.00 65 ± 22.91 a 70 ± 8.66 
Ethyl acetate fraction 15 mg/kg BW/day  80 ± 8.66 90 ± 0.00 abc 95 ± 22.91 
Ethyl acetate fraction 30 mg/kg BW/day 90 ± 30.00 105 ± 15.00 bc 95 ± 22.91 
Ethyl acetate fraction 60 mg/kg BW/day 90 ± 0.00 115 ± 8.66 c 110 ± 17.32 
Ethanol extract 50 mg/kg BW/day 95 ± 8.66 100 ± 17.32 bc 80 ± 22.91 
Ethanol extract 100 mg/kg BW/day 95 ± 8.66 110 ± 17.32 c 80 ± 17.32 
Ethanol extract 200 mg/kg BW/day 100 ± 17.32 110 ± 17.32 c 100 ± 17.32 
Aspirin 42,2 mg/kg BW/day 95 ± 8.66 115 ± 8.66 c 115 ± 8.66 
Results are expressed means ± SD, Duncan post Hoc test are shown by little letter, different letter at the same coloumn are significantly different
 among treatment groups at confidence interval 95 %
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Wijaya, 1998). Active thrombocyte release ADP and throm-
boxane A2 and initiate aggregation of thrombocyte and vaso-
constriction. Thrombocyte aggregation is important factor in 
thrombose formation in uncontrol blood clotting (Wu et al., 
2007). The high LDL and low HDL level in dyslipidemic rats 
(Table 3) were shorter clotting and bleeding time compared 
to negative control, this research was verified that elevating 
levels of LDL and low levels of HDL are widely used for pre-
dicting risk to atherosclerosis (Sevanian et al., 1998).
Velvet bean seed ethanol extract and ethyl acetate frac-
tion contain high antioxidant and flavonoids (Widowati and 
Retnaningsih, 2007; Widowati et al., 2007, Widowati et al., 
2010), were capable to prolong the clotting and bleeding time 
at day 10 in dyslipidemic rats (Table 2,3). This research was 
verified with previous study that flavonoids could reduce 
LDL oxidation, an important step in atherogenesis (Setorki 
et al., 2009) through free radicals scavenger mechanism. 
Based on the data (Table 1) displayed that velvet bean seed 
extract and ethyl acetate fration had high antioxidant activity 
(Widowati and Retnaningsih, 2007), and were capable to re-
duce lipid peroxidation and decreased MDA, LDL level com-
pared to dyslipidemic rats which were not given extract and 
ethyl acetate fraction as antioxidant and flavonoid sources. 
Antioxidant activity of polyphenols were shown to possess 
many biological properties including the inhibition of platelet 
aggregation, vasorelaxing activity, modulation of lipid me-
tabolism, and inhibition of LDL oxidation (Agli et al., 2004). 
In Table 2, the LDL in dyslipidemic rats 14.33 mg/dL was 
higher than negative control (8.00 mg/dL) and will highly in-
fluenced the oxidative damage (MDA 11.77 mmol/L), due to 
the high LDL level accelerating atheroginicity (Parthasara-
thy et al., 1999). The oxidation of LDL was led by free rad-
ical-mediated chain reaction, yielding phosphatidylcholine 
hydroperoxide (PCOOH) cholesteryl ester hydroperoxide 
(CEOOH) as the primary oxidations product (Noguchi et al., 
1998). It means that high LDL level increases oxidized LDL 
(ox-LDL) and MDA level (Table 2) and play role in athero-
sclerosis. LDL level increases amounts of thiobarbituric acid 
reactive materials (often attributed to increase amounts of 
MDA, 4-hydroxynonenal, and related carbonyl compounds), 
lipid peroxides, cholesterol oxides, decrease amounts of spe-
cific phospholipids, showed increase lysophospholipids and 
diminish antioxidants level (Sevanian et al., 1998). The evi-
dence indicate that oxidative modification of LDL may play 
a causative role in atherosclerosis (Sevanian et al., 1998). 
Oxidized LDL is cytotoxic to endothelial cells, and nLDL 
is not toxic (Sevanian et al., 1998; Halliwel and Gutteridge, 
1999). The previous research indicated that atherogenicity 
was due to oxidative damage to LDL cholesterol. Modified 
or oxidized LDL (ox-LDL) has been shown to accelerate 
several steps in atherosclerosis including endothelial dam-
age, monocyte/macrophage recruitment, increased uptake 
of LDL by foam cells (Hannekens, 1999). The oxidation of 
LDL is important in atherosclerosis, it is likely to occur in the 
subendothelial intima rather than the plasma (Parthasarathy, 
1999). In Table 1, showed that dyslipidemic rats, high LDL 
concentration increased ox-LDL. The MDA level in dyslipi-
demic rat was higher 11.77 mmol/L compared to normal rat 
was 5.52 mmol/L, furthermore the bleeding time at 10 day of 
dyslipidemic rats were shorter than those in normal rats. This 
research result supports previous research, that oxLDL could 
accelerate atherosclerosis stages including endothelial dam-
age, monocyte/macrophage recruitment, increased uptake of 
LDL by foam cells, alteration in vascular tone (Hannekens, 
1999; Parthasarathy et al., 1999). The oxidative modified 
LDL is taken up by macrophage, which results in its unregu-
Tabel 3.  The bleeding time of dyslipidemia rats given ethanol extract and ethyl acetate of velvet bean seed 
Treatment Bleeding time0 day
Bleeding time
10 day
Bleeding time
20 day
Negative control 95 ± 8.66 100 ± 17.32 bc 100 ± 8.66 bc
Positive control 70 ± 8.66 65± 8.66 a 65 ± 8.66 a
Ethyl acetate fraction 15 mg/kg BW/day 65 ± 8.66 85 ± 17.32 ab 85 ± 8.66 abc
Ethyl acetate fraction 30 mg/kg BW/day 70 ± 17.32 95± 8.66 abc 85 ± 8.66 abc
Ethyl acetate fraction 60 mg/kg BW/day 70 ± 8.66 120 ± 30.00 c 95 ± 8.66 bc
Ethanol extract 50 mg/kg BW/day 80 ± 17.32 90 ± 25.98 abc 80 ± 17.32 ab
Ethanol extract 100 mg/kg BW/day 75 ± 15.00 95 ± 8.66 abc 80 ± 17.32 ab
Ethanol extract 200 mg/kg BW/day 75 ±15.00 110 ± 8.66 bc 95 ± 17.32 ab
Aspirin 42,2 mg/kg BW/day 70 ± 17.32 115 ± 0.00 bc 105 ± 0.00 c
Results are expressed means ± SD, Duncan post Hoc test are shown by little letter, different letter at the same coloumn are significantly different among treatment 
groups at confidence interval 95 %
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lated uptake and eventual formation of foam cells as the early 
stages in cardiovasular disease (Noguchi et al., 1998). Ath-
erosclerosis is a systemic inflammatory disease characterized 
by the accumulation of monocytes/macrophages and lympho-
cytes in the intima of large arteries. Rupture or erosion of the 
advanced lesion initiates platelet activation and aggregation 
on the surface of the disrupted atherosclerotic plaque (Mass-
berg et al., 2002). The term of endothelial dysfunction has 
been used to refers several pathological conditions, includ-
ing altered anticoagulant and anti-inflammatory properties of 
the endothelium, impaired modulation of vascular growth, 
and dysregulation of vascular remodeling (Cai and Harrison, 
2000), damaging the platelet activity, leukocyte adhesion, and 
thrombosis and is intimately involved in the development of 
atherosclerosis (Heitzer et al., 2001). Increased production 
of oxygen-derived free radicals such as the superoxide anion 
has been linked to impaired endothelial vasomotor function 
(Heitzer et al., 2001). Ox-LDL is the key event in endothelial 
injury and dysfunction. LDL in the subendothelial space, un-
dergoes progressive oxidation and activates the expression of 
macrophage chemotatic protein 1 (MCP-1) and macrophage 
colony stimulating fator (M-SF) in the endothelium. MCP-1 
and M-CSF promote the entry and maturation of monocytes 
to macrophages, which further ox-LDL. Ox-LDL is specifi-
cally recognized by the scavenger receptor of macrophages 
and once internalized, formation of foam cells. Ox-LDL and 
modified LDL induce endothelial, associated with changes of 
the adhesivenes to leukocytes or platelet and to wall perme-
ability (Virgilli and Scaccini, 2001).
Extract and ethyl acetate fraction of velvet bean could 
prolong the clotting and bleeding time, and was verified with 
the previous research that using apple juice as flavonoids 
source (total flavonoids 1.36 ± 0.03 g/100 mL equivalent cat-
echin and total anthocyanin 3.05 ± 0.85 mg/100 g) in cho-
lesterolemic rabbit, significantly decreased fibrinogen and 
factor VII levels compared to high-cholesterol group (Setorki 
et al., 2009). Based on the data (Table 2,3) displayed velvet 
bean seed extract and ethyl acetate fraction could prolong the 
clotting and bleeding time due to contained high flavonoid 
(Widowati et al., 2007). The previous research showed that 
ethyl acetate fraction of velvet bean seed 500 µg/mL exhibi-
ted antiaggregation platelet against adhenosin diphosphate 
(ADP) inducer by in vitro test (Widowati and Ratnawati, 
2009). Flavonoids are subgroup of polyphenol, capable of : 
1). inhibiting atherosclerosis, endothelial disruption, leuco-
cyte activity, adhesion, aggregation platelet, decrease LDL 
level in normal and hypercholesterolemic rats, also inhibit 
in vitro LDL oxidation; 2). decreasing atherogenesis, inhibit 
hyperlipidemia, inhibit triglyceride accumulation in blood 
and liver, decrease phospholipid and fatty acids in rat’s tis-
sue (Koshy et al., 2001; Hidgon, 2005). Giving 10 mL and 5 
mL apple juice in cholesterolemic rabbits, the atherosclerotic 
thickness of right and left coronary arteries was 0.8 – 1.4 and 
0.92 -1.92, respectively and the plaque degree for both was 
grade 1. High cholesterol groups, right and left coronary ar-
teries, the atherosclerotic thickness of right and left coronary 
arteries was 3.47 ± 0.37 and 3.28 ± 0.26, respectively and 
the plaque degree in both was grade 3. Giving apple juices 
as flavonoid sources decreased the plaque degrees (Setorki et 
al., 2009). Atherosclerotic changes were absent in normal diet 
group, whereas in the intimal surface of the coronary arteries 
from high-cholesterol diet group were seen many fat-laden 
macrophages. The cytoplasm of the macrophages filled with 
lipid droplets (foam cell) as the result of lipid digestion by the 
macrophage. Apple juice as flavonoids source may be useful 
in preventing hypercholesterolemic atherosclerosis and low-
ering the related risk of coronary artery disease (Setorki et 
al., 2009).
Flavonoids play role as an antiinflammation, antioxi-
dant, antiallergic, hepatoprotective, antitrombotic, neuropro-
tective and anticarcinogenic (Ganapaty et al., 2007). Antiag-
gregation platelet activity of flavonoid is through inhibition 
of thromboxane A2 mechanism. The inhibited thromboxane 
A2 stimulates adenyl cyclase further increase cAMP and the 
increasing cAMP will reduce ion Ca (calcium) concentration 
in thrombocyte, furthermore inhibit aggregation and adhesion 
(Hoffbrand and Pettit, 1987), prolong clotting and bleeding 
time.
Flavonoids protect against atherosclerosis, through re-
ducing the susceptibility of LDL to oxidation (Benito et al., 
2002), and vasodilator properties observed in vitro (Benito et 
al., 2002)
The research results showed that giving velvet bean 
seed extract 200 mg/kg BW/day increased HDL level (31.67 
mg/dL) compared to positive control (24.33 mg/dL) (Table 
2). This results were verified with previous study that HDL 
concentration inhibited atherosclerosis progression and ad-
vance cardiovascular disease (Sevanian et al., 1998; Santoso 
and Setiawan, 2005).
Based on Table 2 showed that aspirin prolonged clot-
ting time in dyslipidemic rats and prolonged bleeding time 
in dyslipdemic rats (Table 3), aspirin is antiplatelet agent, 
medication that blocks the formation of blood clots by pre-
venting the clumping of platelets. Aspirin as anti-thrombotic 
compounds is through the inhibition of platelet cyclooxyge-
nase-1 (COX-1) by irreversible acetylation of a specific ser-
ine moiety, thereby blocking the formation of thromboxane 
A2 (TXA2) for the life time of the platelets (McKee et al., 
2002; Ohmori et al., 2006). Table 1 showed that aspirin has 
no antioxidant effect, can not decrease the MDA level, has no 
anticholesterol activity, and can not decrease the LDL level in 
dyslipidemic rats.
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CONCLUSIONS
Ethanol extract and ethyl acetate fraction of velvet bean 
seed exhibited antiplatelet aggregation in dyslipidemic rats, 
treated with ethanol extract 100 mg/kg BW/day, 200 mg/kg 
BW/day and ethyl acetate fraction 60 mg/kg BW/day pro-
longed the clotting time at day 10, ethanol extract 200 mg/
kg BW/day and ethyl acetate fraction 60 mg/kg BW/day pro-
longed the bleeding time at day 10. 
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